In-Hospital and 1-Year Outcomes Among Percutaneous Coronary Intervention Patients With Chronic Kidney Disease in the Era of Drug-Eluting Stents. A Report From the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) Registry

JACC: Cardiovascular Interventions

Volumn 2, Issue 1, 2009, Pages 37-45

  Latif, Faisal ^a   Kleiman, Neal S ^b   Cohen, David J ^c   Pencina, Michael J ^d   Yen, Chen Hsing ^d   Cutlip, Donald E ^d   Moliterno, David J ^e   Nassif, Deborah ^d   Lopez, John J ^f   Saucedo, Jorge F ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^d HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

Author keywords

angioplasty; chronic kidney disease; coronary disease; drug eluting stents

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR; FIBRINOLYTIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CHRONIC KIDNEY DISEASE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE CLEARANCE; DEMOGRAPHY; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOSPITAL CARE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; STABLE ANGINA PECTORIS; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; HOSPITAL PATIENT; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; RANDOMIZED CONTROLLED TRIAL; REGISTER; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INPATIENTS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; REGISTRIES; TIME FACTORS; TREATMENT OUTCOME; ANGIOPLASTY, BALLOON, CORONARY;

EID: 58249144471     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.06.012     Document Type: Article

References (28)

1. U.S. Renal Data System. USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States (2006), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
2. Coresh J., Astor B.C., Greene T., Eknoyan G., and Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
3. Rubenstein M.H., Harrell L.C., Sheynberg B.V., Schunkert H., Bazari H., and Palacios I.F. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?. Circulation 102 (2000) 2966-2972
4. Best P.J.M., Lennon R., Ting H.H., et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39 (2002) 1113-1119
5. Kahn J.K., Rutherford B.D., McConahay D.R., Johnson W.L., Giorgi L.V., and Hartzler G.O. Short and long-term outcome of percutaneous trans-luminal coronary angioplasty in chronic dialysis patients. Am Heart J 119 (1990) 484-489
6. Koyangi T., Nishida H., Kitamura M., et al. Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous trans-luminal coronary angioplasty in renal dialysis patients. Ann Thorac Surg 61 (1996) 1793-1796
7. Coca S.G., Krumholz H.M., Garg A.X., and Parikh C.R. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 296 (2006) 1377-1384
8. Jacob S., Cohen D.J., Massaro J., Niemyski P., Maresh K., and Kleiman N. Design of a registry to characterize "real-world" outcomes of percutaneous coronary revascularization in the drug-eluting stent era. Am Heart J 150 (2005) 887-892
9. Win H.K., Caldera A.E., Maresh K., et al. Clinical outcomes and stent thrombosis following off-label use of drug eluting stents. JAMA 297 (2007) 2001-2009
10. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
11. Smith Jr. S.C., Dove J.T., Jacobs A.K., et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 37 (2001) 2215-2238
12. Bovill E.G., Terrin M.L., Stump D.C., et al. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. Ann Intern Med 115 (1991) 256-265
13. Sadeghi H.M., Stone G.W., Grines C.L., et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 108 (2003) 2769-2775
14. Mathis A.S., and Gugger J.J. Percutaneous coronary intervention-related bleeding risk factors in current practice. Ann Pharmacother 39 (2005) 1627-1633
15. Attallah N., Yassine L., Fisher K., and Yee J. Risk of bleeding and restenosis among chronic kidney disease patients undergoing percutaneous coronary intervention. Clin Nephrol 64 (2005) 412-418
16. Berger P.B., Best P.J., Topol E.J., et al. The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial. Am Heart J 149 (2005) 869-875
17. Alexander K.P., Chen A.Y., Roe M.T., et al., CRUSADE Investigators. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA 294 (2005) 3108-3116
18. Alexander K.P., Chen A.Y., Newby L.K., et al. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. Circulation 114 (2006) 1380-1387
19. Reddan D., Szczech L.A., O'Shea S., and Califf R.M. Anticoagulation in acute cardiac care in patients with chronic kidney disease. Am Heart J 145 (2003) 586-594
20. Soslau G., Brodsky I., Putatunda B., Parker J., and Schwartz A.B. Selective reduction of serotonin storage and ATP release in chronic renal failure patients platelets. Am J Hematol 35 (1990) 171-178
21. Halkin A., Mehran R., Casey C.W., et al. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV trial. Am Heart J 150 (2005) 1163-1170
22. Das P., Moliterno D.J., Charnigo R., et al. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Inv Cardiol 18 (2006) 405-408
23. Zhang R.Y., Ni J.W., Hu J., et al. Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention. Chin Med J 119 (2006) 1176-1181
24. Karvouni E., Kastritis D.G., and Ioannidis J.P. Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. J Am Coll Cardiol 41 (2003) 26-32
25. Lemos P.A., Arampatzis C.A., Hoye A., et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 95 (2005) 167-172
26. Nakazawa G., Tanabe K., Aoki J., et al. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Cath Cardiovasc Interv 69 (2007) 808-814
27. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
28. Tonelli M., Bohm C., Pandeya S., Gill J., Levin A., and Kiberd B.A. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis 37 (2001) 484-489